DIALYSIS · CCN 112882

USRC Valdosta Home Program

VALDOSTA, GA 31602

DialysisProfitUS Renal Care, Inc.
$2.7M
TOTAL REVENUE
1.4%
OPERATING MARGIN
1 / 5
STAR RATING
13
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$2.7M
Total costs
$2.7M
Operating income (rev − costs)
$39K
Operating margin
1.4%
Total charges
$2.7M
Total treatments
7,811
Dialysis stations
—

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Percentage of Adult PD Patients with Kt/V >= 1.7
DFC_ADULT_PD_KTV
9744—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.9277—
Fistula Rate
DFC_FISTULA_RATE
55.627—
Five Star Rating
DFC_FIVE_STAR
1——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.2144—
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
193.158—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
169—
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
4527—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
54233—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
1749—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
30.468—
Standardized ED Visits Ratio
DFC_SEDR
0.9335—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
109.330—